Event Date: July 18, 2026
XenoFarma successfully organized a specialized scientific meeting on July 18, 2026, bringing together a distinguished group of radiotherapists to discuss important gastrointestinal considerations encountered during radiotherapy treatment.
The session focused on evidence-based approaches to optimizing gastrointestinal care before and during radiotherapy. Particular attention was given to the clinical role of PURGOTEC® in bowel preparation and rectal evacuation, especially in patients undergoing prostate radiotherapy, where appropriate bowel management contributes to treatment accuracy and patient comfort.
The meeting also highlighted the benefits of TRIO-ZYME® in the management of common gastrointestinal symptoms, including dyspepsia, bloating, indigestion, and occasional acidity. The discussion reviewed practical considerations for supporting digestive health and improving patient comfort throughout the course of treatment.
The session encouraged active scientific discussion and exchange of clinical experience among participants, providing an opportunity to review practical strategies that can be incorporated into routine radiotherapy practice.
XenoFarma remains committed to supporting continuous medical education and advancing multidisciplinary collaboration through scientific meetings that promote evidence-based patient care and improved clinical outcomes.
